SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study)
Titel:
SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study)
Auteur:
Borghaei, Hossein Redman, Mary W. Kelly, Karen Waqar, Saima N. Robert, Francisco Kiefer, Gauri J. Stella, Philip J. Minichiello, Katherine Gandara, David R. Herbst, Roy S. Papadimitrakopoulou, Vassiliki A.